Botulinum Toxin Type A Injection [Botox]
Sponsors
Hugel, All India Institute of Medical Sciences, University of Kansas Medical Center, National Cheng-Kung University Hospital, Istanbul Medipol University Hospital
Conditions
Acute Acquired Comitant EsotropiaAnal Fissure ChronicBotulinum ToxinCervical DystoniaCricopharyngeus Muscle DysfunctionDysphagia, Late Effect of StrokeEsophagogastric Junction DisorderGlabellar Lines
Phase 1
Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia
CompletedNCT04171258
Start: 2020-05-26End: 2021-10-26Updated: 2022-04-22
Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder
CompletedNCT04186442
Start: 2020-05-12End: 2021-10-26Updated: 2022-04-15
To Compare the Safety and Efficacy of HG-102 With Botox® in the Improvement of Moderate to Severe Glabellar Lines.
CompletedNCT04944953
Start: 2021-06-11End: 2021-12-16Updated: 2022-05-24
Phase 2
Phase 3
Phase 4
Botulinum Toxin Type a Injection to Prevent Keloid Recurrence
CompletedNCT05072821
Start: 2020-10-13End: 2024-03-20Updated: 2024-11-07
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
Not yet recruitingNCT07295288
Start: 2026-02-01End: 2026-06-30Target: 50Updated: 2025-12-29
Unknown Phase
Role of EndoFLIP in the Diagnostic Paradigm of Esophagogastric Junction Outflow Obstruction
WithdrawnNCT04938102
Start: 2022-07-31End: 2024-10-11Updated: 2024-10-21
The Efficacy of Botulinum Toxin Alone Versus Combined Botulinum Toxin and Topical Diltiazem in Chronic Anal Fissure
CompletedNCT05797220
Start: 2016-11-04End: 2024-08-30Updated: 2024-09-04
Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea
RecruitingNCT06282679
Start: 2022-04-01End: 2024-06-28Target: 30Updated: 2024-02-28
Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study
CompletedNCT06966999
Start: 2019-01-01End: 2023-06-01Updated: 2025-05-13